Ceftpel S 1000mg/500mg Injection
Marketer
Ashwa Healthcare
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Ceftpel S 1000mg/500mg Injection
Combiflox, a 1000mg/500mg injectable dual-action antibiotic, combats diverse bacterial infections. Its mechanism halts microbial proliferation, thereby containing infection spread. Administration must be solely under a physician's guidance. Consistent adherence to the prescribed regimen is crucial; premature cessation may compromise efficacy. Complete the full course even with symptom improvement. Minor side effects, including nausea, vomiting, diarrhea, and dyspepsia, may occur. Severe reactions necessitate immediate medical attention. Allergic responses (rash, pruritus, edema, dyspnea) require prompt emergency care. Inform your doctor of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if drowsiness or dizziness develops. Adequate rest, balanced nutrition, and hydration will aid recovery. Your doctor may order lab work to monitor therapeutic response.
Primary Ingredients of Ceftpel S 1000mg/500mg Injection
No text provided to rephrase.
Uses of Ceftpel S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Ceftpel S 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ceftpel S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftpel S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ceftpel S 1000mg/500mg Injection works:
Ceftriaxone and sulbactam, combined as Ceftpel S 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to multiply. Sulbactam's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol ingestion alongside Ceftpel S 1000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ceftpel S 1000mg/500mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, clinical data in humans are scarce.
Breast feedingCAUTION
Administering Ceftpel S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Ceftpel S 1000mg/500mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceftpel S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Administering Ceftpel S 1000mg/500mg Injection requires caution in patients exhibiting severe hepatic impairment. Dosage modification of Ceftpel S 1000mg/500mg Injection might be necessary. Physician consultation is advised. Altering the Ceftpel S 1000mg/500mg Injection dosage is not suggested for individuals with mild or moderate liver dysfunction.
What if you forget to take Ceftpel S 1000mg/500mg Injection :
Omission of a Ceftpel S 1000mg/500mg Injection dose requires contacting your physician.
Facts to Know About Ceftpel S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently